-
Abstract Number: PB2222
What Kind of Thrombophilia in Reunion Island?
-
Abstract Number: PB1917
What to Expect about Antiphospholipid Positivity in Otherwise Healthy Patients: Is There a Real Risk of Thrombosis?
-
Abstract Number: PB0005
White Clot is More Permeable and Stronger than the Red Clot
-
Abstract Number: PB0647
Who May Benefit from Direct Oral Anticoagulant Level Monitoring? A Systematic Literature Review
-
Abstract Number: PB0296
Whole Blood Coagulation Profiles at the Time of Emergency Unit Admission in Patients with Major Trauma
-
Abstract Number: PB1210
Whole Exome Sequencing Approach to Address the Genetic Heterogeneity of Inherited Platelet Disorders
-
Abstract Number: PB0233
Whole Genome Sequencing Study of Coagulation Factor VIII and von Willebrand Factor Reveals New Genetic Associations
-
Abstract Number: PB1553
WISH-QoL Study: Assessment of Health-Related Quality of Life and Health-Economic Aspects in Patients with von Willebrand Disease in France: Results from the 2nd Interim Analysis on the 355 Enrolled Patients
-
Abstract Number: PB2555
Women’s Experience of Bleeding and Adverse Events Associated with Postpartum Pharmacological Thromboprophylaxis: A Prospective Cohort Study
-
Abstract Number: PB0811
X Chromosome Inactivation: A Modifier of Factor VIII and IX Plasma Levels in Haemophilia Carriers
-
Abstract Number: PB0240
X-ray Crystallography and Hemostatic Activities of a Neutralizing Anti-TFPI Antibody, Marstacimab
-
Abstract Number: PB0528
XIIa-Dependent Fibrinolysis in Patients with Ph-Negative Myeloproliferative Neoplasms (MPN)
-
Abstract Number: PB1930
β2-Glicoprotein I (β2GpI) Is a Fibrinogen Binding Protein
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.